Stocktwits on MSN
Biohaven’s phase II depression trial falls short, but analysts downplay impact – Wall Street looks ahead to epilepsy data
Analyst Myles Minter noted that the company’s pivotal Phase III study of BHV-7000 in focal-onset epilepsy in the first half ...
Videos that present inaccurate and potentially harmful information about epilepsy drew more views on TikTok than accurate ...
A powerful moment unfolded at a heated congressional hearing when witness Nick Stehle said that his son, who has severe ...
Some of her efforts have met with discouragement, but Jessica Novoa has persevered, seeking outlets for her art and music ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback